Slovenia vs United Arab Emirates: Proportion of the target population who received the final dose of
Slovenia
43.0%
in 2024
United Arab Emirates
46.0%
in 2024
Slovenia rank
82nd
United Arab Emirates rank
79th
Proportion of the target population who received the final dose of over time
- Slovenia
- United Arab Emirates
How they compare
United Arab Emirates currently reports 46.0% against 43.0% in Slovenia, a difference of 3.0%.
That makes United Arab Emirates's figure about 1.1 times Slovenia's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Slovenia ahead.
Slovenia ranks 82nd and United Arab Emirates ranks 79th of 107 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Slovenia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.5% | 25.5% | 27.0% | Slovenia |
| 2020s | 45.4% | 34.2% | 11.2% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Slovenia or United Arab Emirates?
- United Arab Emirates, at 46.0% against 43.0% in Slovenia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Slovenia and United Arab Emirates?
- 3.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Slovenia and United Arab Emirates?
- 7 years are reported by both, from 2018 to 2024.
- How do Slovenia and United Arab Emirates rank globally for proportion of the target population who received the final dose of?
- Slovenia ranks 82nd and United Arab Emirates ranks 79th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.